Ethical, Legal, and Societal Implications (ELSI) in the research infrastructure context

Similar documents
Towards Code of Conduct on Processing of Personal Data for Purposes of Scientific Research in the Area of Health

Realising the FNH-RI: Roadmap. Karin Zimmermann (Wageningen Economic Research [WUR], NL)

Ethical Governance Framework

25 th Workshop of the EURORDIS Round Table of Companies (ERTC)

EMBRC-ERIC: A platform for Innovation

WP6 Genomics Organizing the societal debate on the use of genomic information in healthcare

Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA

EU Research Integrity Initiative

The Biological and Medical Sciences Research Infrastructures on the ESFRI Roadmap

THE ASEAN FRAMEWORK AGREEMENT ON ACCESS TO BIOLOGICAL AND GENETIC RESOURCES

The EFPIA Perspective on the GDPR. Brendan Barnes, EFPIA 2 nd Nordic Real World Data Conference , Helsinki

Towards a Magna Carta for Data

Operational Objectives Outcomes Indicators

Genetic Resources and Intellectual Property: Recent developments under the Convention on Biological Diversity

Technical Assistance. Programme of Activities

DERIVATIVES UNDER THE EU ABS REGULATION: THE CONTINUITY CONCEPT

Tuning-CALOHEE Assessment Frameworks for the Subject Area of CIVIL ENGINEERING The Tuning-CALOHEE Assessment Frameworks for Civil Engineering offers

Justice Select Committee: Inquiry on EU Data Protection Framework Proposals

Research Infrastructures from FP7 to Horizon 2020

Mobilisation and Mutual Learning (MML) Action Plans on Societal Challenges

SafeNano Norway in from concept to reality?

The political context of Research Infrastructures Consequences for impact and evaluation

Report. RRI National Workshop Germany. Karlsruhe, Feb 17, 2017

clarification to bring legal certainty to these issues have been voiced in various position papers and statements.

The 45 Adopted Recommendations under the WIPO Development Agenda

Our position. ICDPPC declaration on ethics and data protection in artificial intelligence

Marine biological diversity of areas beyond national jurisdiction. Legal and policy framework

ANEC response to the CEN-CENELEC questionnaire on the possible need for standardisation on smart appliances

United Nations Framework Convention on Climate Change UNFCCC EXPERT GROUP ON TECHNOLOGY TRANSFER FIVE YEARS OF WORK

Human Rights Approach

Human Biological Material Collection, Storage and Use

The New Delhi Communiqué

International Cooperation in Horizon 2020

Non-ferrous metals manufacturing industry: vision for the future and actions needed

WIPO Development Agenda

Progressive Licensing and the Modernization of the Canadian Regulatory Framework

Ministry of Justice: Call for Evidence on EU Data Protection Proposals

BBMRI-ERIC WEBINAR SERIES #2

The General Data Protection Regulation and use of health data: challenges for pharmaceutical regulation

Social Innovation 2015: Pathways to Social Change Vienna, November 18 th, Maria Schwarz-Woelzl (ZSI) & Wolfgang Haider (ZSI)

Global Alliance for Genomics & Health Data Sharing Lexicon

Governance and Ethics of Nanotechnology

Supporting Innovation through Regulation and Science

Søren Flensted Lassen, Novozymes A/S 07 June 2016

Rethinking the role of Social Sciences and Humanities (SSH) in Horizon 2020: toward a reflective and generative perspective

IoT governance roadmap

Towards EU-US Collaboration on the Internet of Things (IoT) & Cyber-physical Systems (CPS)

European Charter for Access to Research Infrastructures - DRAFT

The Biological Weapons Convention and dual use life science research

Interaction btw. the GDPR and Clinical Trials Regulation

Marie Skłodowska-Curie Actions Individual Fellowships. Cross-cutting issues in MSCA

Water, Energy and Environment in the scope of the Circular Economy

National and European-level strategies for implementing open access research infrastructures. Euro-BioImaging Stakeholder meeting Wien, Jan 21, 2013

Serving the humanities: daydreams and nightmares

Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy)

DRAFT. Cardiac Safety Research Consortium CSRC. Membership Committee Charter. 12September2018. Table of Contents

Implementation of Directive 2010/63/EU: - the animal welfare perspective

Medical Technology Association of NZ. Proposed European Union/New Zealand Free Trade Agreement. Submission to Ministry of Foreign Affairs & Trade

Stakeholders Acting Together On the ethical impact assessment of Research and Innovation

The BGF-G7 Summit Report The AIWS 7-Layer Model to Build Next Generation Democracy

Privacy Policy Framework

Communication and Dissemination in HORIZON 2020 European Commission Directorate-General for Research and Innovation

Digital transformation in the Catalan public administrations

DoReMi-MELODI Training and Education Forum Introduction and background

The Nagoya Protocol. Overview of the Nagoya Protocol

Update on Taxonomy Release version EIOPA Insurance & Reinsurance Stakeholder Group meeting Frankfurt, 29 March2017

International initiatives in data sharing: OECD, CODATA and GICSI. Yukiko Fukasaku Innovmond Padova 21 September 2007

Banco de Sabadell, S.A. Policy on communication and contacts with shareholders, institutional investors and proxy advisors

At its meeting on 18 May 2016, the Permanent Representatives Committee noted the unanimous agreement on the above conclusions.

Brief presentation of the results Ioana ISPAS ERA NET COFUND Expert Group

COMMISSION RECOMMENDATION. of on access to and preservation of scientific information. {SWD(2012) 221 final} {SWD(2012) 222 final}

NCRIS Capability 5.7: Population Health and Clinical Data Linkage

What Makes International Research Ethical (Or Unethical)? Eric M. Meslin, Ph.D Indiana University Center for Bioethics

Legal Aspects of Identity Management and Trust Services

TGA Discussion Paper 3D Printing Technology in the Medical Device Field Australian Regulatory Considerations

Pan-Canadian Trust Framework Overview

Stakeholder Involvement. Nuclear Issues. INSAG and IAEA perspective BASIS FOR KNOWN PUBLIC CONCERN. INSAG-20 Stakeholder Involvement in

Guidance on the anonymisation of clinical reports for the purpose of publication in accordance with policy 0070

Herts Valleys Clinical Commissioning Group. Review of NHS Herts Valleys CCG Constitution

European Network for Health Technology Assessment (EUnetHTA) Joint Action 3

Emerging biotechnologies. Nuffield Council on Bioethics Response from The Royal Academy of Engineering

JBA ABS Symposium on Digital Sequence Information. 28 February 2018 Tokyo

EOSC Governance Development Forum 6 April 2017 Per Öster

Big data: a complex and evolving regulatory framework

Open access to research data in a European policy context

Final Report. MAASiFiE. Report Nr 1.2 May 2017

Access to Research Infrastructures under Horizon 2020 and beyond

Materials in the knowledgesociety and the role of the EU 7th Framework Programme

ENVRIPLUS GENERAL INTRODUCTION. Ari Asmi ENVRIplus director. H2020 Project Project Number:

GIE response to public consultation Interoperability NC of ENTSOG

Engaging UK Climate Service Providers a series of workshops in November 2014

INTERIM EVALUATION METHODOLOGY FOR LARGE RESEARCH INFRASTRUCTURES

RADIO SPECTRUM POLICY GROUP. Commission activities related to radio spectrum policy

Developing Research Infrastructures for 2020 and beyond

IV/10. Measures for implementing the Convention on Biological Diversity

Guidance on the anonymisation of clinical reports for the purpose of publication

BioMedBridges Training Completing the circle between developers and users. BioMedBridges AGM 12 March 2014, Florence Cath Brooksbank & Tom Hancocks

ISO/TR TECHNICAL REPORT. Intelligent transport systems System architecture Privacy aspects in ITS standards and systems

Science Impact Enhancing the Use of USGS Science

January 1 st, 2018 Sample Current Affairs

Transcription:

Ethical, Legal, and Societal Implications (ELSI) in the research infrastructure context EMBRC workshop, 13 September 2016 Stephanie Suhr www.elixir-europe.org

Research infrastructures make resources available to the scientific community. How do you implement regulatory requirements... for data and/or samples that were produced in a specific context and are now used for research in many different contexts, and across a research infrastructure?

Background: ELIXIR ELIXIR is a distributed infrastructure with organisationally independent Nodes ELIXIR Nodes make key data resources available to the research community The legal basis for ELIXIR requires that each Service has its own functioning ethics and regulatory oversight in place

An overarching framework ELIXIR has developed an Ethics Policy which will: Identify potential risks Clarify roles and responsibilities Provide first guidance on high level principles From ELIXIR Ethics policy: 4.4 Public benefit Biomedical research serves the greater well-being of all humankind. Its benefit to society consists in achieving greater insight into the foundations of biology as well as in integrating its findings into clinical care. For the sake of realising societal benefit, it is necessary to ensure the broadest participation, which includes the general public, in sharing the benefits of scientific advancement.

Main concerns of stakeholders The policy should...not introduce additional administrative or technical burden...not make requirements that could come in conflict with other applicable legislation (e.g. national regulations or implementation of e.g. EU-level legislation)...be very clear on what the ELIXIR Service providers are and what they are NOT responsible for...not create ambiguities with respect to responsibilities...not interfere with processes in place at Nodes...emphasise and support the principle of open sharing of data for research.

This is key: clarify the respective roles! The policy defines the following roles in the context of data provision via ELIXIR Services; each of these has different, clearly defined responsibilities: Data Provider means the individual researcher or investigator or body of researchers or investigators that submits data for access and use in the context of an ELIXIR Service Service Provider refers to the Node providing an ELIXIR Service (as detailed above) Data User means the individual researcher or investigator or group of researchers or investigators that accesses and/or uses data made available as part of an ELIXIR Service

Data subject (e.g. study participant, patient) Consent User Data Transfer Agreement/Data Access Agreement/Terms of Use The Data Transfer Agreement ensures that data providers and users are aware of their obligations The responsibility for implementing relevant obligations is cascaded down to the data provider (e.g. ethics review) and/or user. ELIXIR Service Data provider (e.g. researcher, consortium) Data Transfer Agreement/ Terms of Use ELIXIR NODE ELIXIR Ethics Policy

COMMON SERVICE ELSI Facilitates & supports cross-border exchanges of human biological resources and data attached for research uses, collaborations and sharing of knowledge, experiences and best practices. Started in February 2015 20+ experts from law, philosophy, social sciences, ethics

ETHICAL, LEGAL AND SOCIETAL ISSUES (ELSI) (WP7, led by BBMRI-ERIC) establishment of a sustainable common service for all BMS RIs dealing with samples and/or data with ethical, legal and social implications development/improvement of patient information and consent templates integration of the common service into the BBMRI-ERIC tool Common Service ELSI 9

ACCOUNTABILITY While making the best use of any entrusted data (given typically for altruistic reasons), data has to be protected from careless handling, misuse and illegal disclosure. Hence, the ultimate responsibility is to use data appropriately, so that neither the expectations nor the efforts of the data providers and users go to waste.

CONTACT CORBEL WP7 ELSI and BBMRI-ERIC Email: michaela.th.mayrhofer@bbmri-eric.eu Web: www.bbmri-eric.eu, www.corbel-project.eu ELIXIR Email: stephanie.suhr@elixir-europe.org Web: www.elixir-europe.org